The hippocampus was selected for analysis not only because the human APP mutant transgene is highly expressed in this brain region (Fig 3A) but it is also highly vulnerable to Aβ and it is where neuropathological changes are initiated early in AD [29]. This evidence concerns the gene APP and Alzheimer disease.